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HDAC3 maintains oocyte meiosis arrest by
repressing amphiregulin expression before
the LH surge
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It is known that granulosa cells (GCs) mediate gonadotropin-induced oocyte meiosis
resumption by releasing EGF-like factors in mammals, however, the detailed molecular
mechanisms remain unclear. Here, we demonstrate that luteinizing hormone (LH) surge-
induced histone deacetylase 3 (HDAC3) downregulation in GCs is essential for oocyte
maturation. Before the LH surge, HDAC3 is highly expressed in GCs. Transcription factors,
such as FOXO1, mediate recruitment of HDAC3 to the amphiregulin (Areg) promoter, which
suppresses AREG expression. With the LH surge, decreased HDAC3 in GCs enables histone
H3K14 acetylation and binding of the SP1 transcription factor to the Areg promoter to initiate
AREG transcription and oocyte maturation. Conditional knockout of Hdac3 in granulosa cells
in vivo or inhibition of HDAC3 activity in vitro promotes the maturation of oocytes inde-
pendent of LH. Taking together, HDAC3 in GCs within ovarian follicles acts as a negative
regulator of EGF-like growth factor expression before the LH surge.
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In mammalian follicles, somatic cells and oocytes constitute anintriguing combination that facilitates mutual signaling andchemical communication to orchestrate oocyte meiotic
maturation in response to gonadotropin stimulation1,2. Fully
grown oocytes are generally arrested at prophase of meiosis I by
the accumulation of cyclin AMP (cAMP) produced by G-protein-
coupled receptor (GPR3/12) signaling to inhibit the activity of
maturation-promoting factor2. Prior to the luteinizing hormone
(LH) surge, follicle-stimulating hormone (FSH) promotes the
secretion of natriuretic peptide precursor type C (CNP/NPPC)
from mural granulosa cells (mGCs) to maintain oocyte meiosis
arrest via the regulation of cyclin GMP (cGMP) produced by
cumulus cells3. cGMP enters oocytes via gap junctions to evoke
meiosis arrest by inhibiting PDE3A activity, which specifically
degrades cAMP4,5.
When the LH surge occurs, LH decreases NPPC/NPR2
expression levels, thereby blocking cGMP synthesis. Simulta-
neously, LH stimulates mGCs to secrete epidermal growth factor
(EGF)-like growth factors, especially amphiregulin (AREG),
epiregulin, and beta-cellulin, which activate EGF receptor (EGFR)
signaling in cumulus cells, leading to cGMP degradation in
response to PDE5 activation and NPR2 inactivation and resulting
in cumulus expansion and oocyte maturation. Finally, LH ter-
minates GC proliferation and induces GC luteinization by acti-
vating extracellular signal-regulated kinase 1/2 signaling6. The
molecular regulatory mechanism of the sex hormone-controlled
expression of NPPC and its receptor (NPR2) in response to FSH/
LH induction in vivo has been reported7,8. However, the signaling
pathway downstream of LH receptor involved in regulating EGF-
like growth factor expression and release has not yet been
characterized.
Although epigenetic modifications are important for germ cell
development1,9–13, few reports have assessed the effects of epi-
genetic modifications in somatic follicular cells on gonadotropin-
induced oocyte maturation. One exception is a study showing
that the level of histone deacetylase 3 (HDAC3) was increased in
GCs retrieved from polycystic ovary syndrome patients who
experienced in vitro fertilization (IVF) failure compared with
those from patients who experienced successful IVF14. HDAC3
belongs to the class I family of HDACs that regulates gene
expression by acetylating lysine residues in histone tails15,16.
Therefore, we hypothesize that HDAC3 levels in GCs may be
associated with oocyte maturation quality. In addition, it remains
unknown whether this association is related to gonadotropin
induction.
Here we demonstrate that HDAC3 inhibits AREG expression
through H3K14 deacetylation prior to the LH surge. Conditional
knockout and inhibition of HDAC3 in GCs increase AREG
expression and result in LH-independent oocyte maturation
in mice.
Results
HDAC3 negatively regulated oocyte maturation. To investigate
the physiological role of HDACs during oocyte maturation in
mice, the expression patterns of all of the class I HDACs in
growing follicles induced by gonadotropins were studied. HDAC3
was the only HDAC in GCs that was upregulated by FSH but
downregulated by LH in vivo and in vitro (Fig. 1a, b; Supple-
mentary Fig. 1a–c), demonstrating its pivotal role in response to
gonadotropin induction during oocyte maturation.
Then, to investigate the precise ovarian function of HDAC3, a
mouse model with GC-specific deletion of Hdac3 was produced
by crossing Hdac3flox/flox female mice with Foxl2-CreERT2
transgenic mice plus Hdac3flox/flox male mice, yielding Hdac3-
flox/flox; Foxl2-CreERT2 (Hdac3cKO) female mice17. Eight days
after the respective intraperitoneal (i.p.) injection of tamoxifen in
18-day-old Hdac3cKO female mice and Hdac3flox/flox female mice
(as a negative control), the western blotting results showed that
HDAC3 protein levels in GCs were markedly decreased in
Hdac3cKO mice compared with the control (Fig. 1c).
To clarify whether the deletion of HDAC3 in GCs correlates with
oocyte maturation, pregnant mare serum gonadotropin (PMSG)
was respectively injected into Hdac3cKO and Hdac3flox/flox mice to
promote follicle development 6 days after tamoxifen administra-
tion. Although Hdac3 depletion was incomplete due to limitations
of the mouse model, we found that the oocytes in Hdac3-deleted
follicles were premature 44 h after PMSG injection, while the
oocytes in ovarian follicles of Hdac3flox/flox mice and in HDAC3-
positive follicles of Hdac3cKO mice, similar to the oocytes in wild-
type (WT) mice and the Foxl2-CreERT2 transgene but not carrying
the floxed allele mice, were still at the germinal vesicle (GV) stage
(Fig. 1d, e; Supplementary Fig. 2a–c). These results indicated that
Hdac3 deletion results in premature oocyte maturation before the
LH surge begins.
To examine whether Hdac3 depletion affects ovarian follicle
survival and follicular atresia, which probably result in oocyte GV
breakdown (GVBD), we performed quantitative polymerase
chain reaction (qPCR) to determine the Bcl2/Bax ratio and
terminal deoxynucleotidyl transferase-mediated dUTP-fluores-
cein nick end labeling (TUNEL) assays to evaluate GC survival.
The results showed that the Bcl2/Bax ratio was normal in
Hdac3cKO mouse ovarian GCs (Supplementary Fig. 2d). Similarly,
TUNEL assays showed that oocyte GVBD in Hdac3 knockout
ovarian follicles was not caused by GC apoptosis or follicular
atresia (Supplementary Fig. 2e). Therefore, the GC-specific
knockout of Hdac3 did not affect the development or survival
of GCs and follicles. Furthermore, LH can terminate ovarian GC
proliferation, and we found that Hdac3 depletion also prohibited
GC proliferation, as indicated by proliferating cell nuclear antigen
staining (Supplementary Fig. 2f). These results indicated that
Hdac3 depletion in ovarian GCs probably mimics the effects of
LH on oocyte maturation and GC proliferation.
HDAC3 repressed AREG expression in GCs before the LH
surge. Given that NPPC and EGF-like growth factors are the two
types of molecules secreted by GCs that are critical in the reg-
ulation of oocyte meiosis progression in response to gonado-
tropin induction3,6, two possible pathways may be responsible for
the effects of Hdac3 deletion on oocyte maturation. Specifically,
Hdac3 deletion in GCs may either downregulate NPPC expres-
sion to relieve oocytes from the inhibitory environment or
upregulate EGF-like growth factors to re-initiate oocyte meiosis.
Interestingly, the mRNA and protein levels of only AREG, one of
the most important EGF-like growth factors that responds to LH
induction, were significantly increased in the ovaries of Hdac3cKO
mice 40 h after PMSG induction (Fig. 2a, b; Supplementary
Fig. 3a). These findings indicate that AREG likely mediates
HDAC3 action in oocyte maturation.
To confirm the HDAC3-mediated regulation of AREG
expression, follicle cultures in vitro were treated with HDACi
4b, a novel, synthetic, specific inhibitor of HDAC1/318. Consistent
with the effects of Hdac3 knockout in vivo, AREG protein and
mRNA levels were significantly elevated by HDACi 4b (Fig. 2c, d).
Moreover, cumulus expansion and oocyte meiosis resumption
were induced by HDACi 4b, while these effects were blocked by
the EGFR inhibitor AG1478, confirming the role of AREG in the
effects of HDAC3 on oocyte maturation (Fig. 2e, f). Furthermore,
chromatin immunoprecipitation (ChIP) analysis showed that,
before the LH surge, more HDAC3 protein was recruited to the
Areg promoter, while 3 h after human chorionic gonadotropin
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(hCG) treatment (equivalent to 3 h after the LH surge), HDAC3
recruitment to the Areg promoter was significantly decreased
(Fig. 2g). HDAC1 was unable to bind the Areg promoter
(Supplementary Fig. 3b). Therefore, we concluded that HDAC3
can specifically bind to the Areg promoter region (−343, −150)
before the LH surge.
Furthermore, cumulus cells in cumulus oocyte complexes
(COCs) were reported to express AREG upon indirect induction
by the LH surge in vivo and upon direct induction by FSH in vitro
during oocyte maturation19,20, suggesting that AREG expression
in cumulus cells is also essential for oocyte maturation. To
examine whether HDAC3 regulates AREG expression in cumulus
cells, we examined Areg expression levels after mouse COCs were
cultured with or without HDACi 4b in vitro in NPPC-M199
medium. The results showed that HDACi 4b was able to promote
oocyte maturation in COCs by directly inducing AREG expression
in cumulus cells (Supplementary Fig. 4). Collectively, the data
indicated that HDAC3 is a negative regulator of AREG expression
that is essential for gonadotropin-induced oocyte maturation.
It is well known that cGMP produced by NPR2 is essential for
oocyte meiosis arrest, which affects upon diffusion via gap
junctions2. AREG activates EGFR signaling in cumulus cells,
which suppresses the guanylyl cyclase activity of NPR2 and
activates PDE5 activity to decrease cGMP levels2,21. To examine
whether the HDAC3 inhibitor induces oocyte maturation by
changing cGMP levels in cumulus cells, we cultured COCs with
8-Br-cGMP alone or in combination with HDACi 4b in M199
medium. The results showed that, while most of the oocytes
in the control group resumed meiosis, the oocytes in the group
treated with 8-Br-cGMP alone arrested at the GV stage; however,
the oocytes in the group treated with HDACi 4b and 8-Br-cGMP
were unable to resume meiosis, with most remaining at the GV
stage (Fig. 2h). Therefore, we concluded that HDAC3 deficiency
induced oocyte maturation by regulating the levels of cGMP,
HDAC3 Hoechst Merge
P0 P24 P48 H1 H2 H3 H4
HDAC3
55 KDa
1.8
1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0
P0 P24 P48 H1 H2 H3 H4
1.2
1.0
0.8
0.6
0.4
0.2
0
120
Follicles in Hdac3cKO
Hdac3cKO
100
G
V
B
D
%
80
60
40
20
0
Hdac3flox/flox
Hdac3flox/flox
Hdac3+ Hdac3 –
a
a
b n = 3 n = 3
n = 21
n = 15n = 50
a
c
d
c ***
2.0
H
D
A
C
3 
re
la
tiv
e 
pr
ot
ei
n 
le
ve
ls
H
D
A
C
3 
re
la
tiv
e 
pr
ot
ei
n 
le
ve
ls
40 KDa
35 KDa
55 KDa
40 KDa
35 KDaGAPDH
HDAC3
Hdac3flox/flox Hdac3cKO
GAPDH
P
48
H
2
H
4
P
0
HDAC3
H
da
c3
flo
x/
flo
x
H
da
c3
cK
O H
da
c3
+
H
da
c3
–
Hoechst
a b c
d e
Fig. 1 HDAC3 negatively regulated oocyte maturation. a HDAC3 (green) levels in GCs decreased dramatically in response to hCG stimulation. Nuclei
were dyed with Hoechst (blue). Scale bar= 100 µm. n= 3 biologically independent experiments. b HDAC3 protein levels were upregulated by PMSG and
downregulated by hCG in a time-dependent manner. P48: 48 h after PMSG treatment, equivalent to 48 h after the FSH surge. H1–H4: 1–4 h after hCG
treatment, equivalent to 1–4 h after the LH surge. n= 3 biologically independent experiments. Data are presented as mean ± SEM, and different letters
(a–d) indicate significant differences among groups (two-sided ANOVA test), P (a, b) < 0.05, P (a, c) < 0.01, P (a, d) < 0.01, P (b, c) < 0.001, P (b, d) < 0.01,
P (c, d) < 0.05. c Hdac3 knockout efficiency was examined and quantified by western blotting analysis. n= 3 biologically independent experiments. Data are
presented as mean ± SEM. Asterisks (*) indicate significant differences at ***P= 0.00007 determined by the two-sided t test. d HDAC3 (green)
immunostaining in the different mouse models revealed oocyte maturation independent of LH in follicles lacking Hdac3 expression (Hdac3-) in GCs,
whereas oocytes in Hdac3-positive (Hdac3+) follicles remained in the GV stage, similar to the situation in Hdac3flox/flox mice. Scale bar= 100 µm. Nuclear
DNA in indicated in blue (Hoechst). e Oocyte maturation (GVBD) rates in follicles with or without HDAC3 expression in the different mouse genotypes.
Source data are provided as a Source Data file.
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which is well known to diffuse from cumulus cells to oocytes
through gap junctions2.
An important question is whether HDACi 4b directly affects
denuded oocyte maturation and developmental competence.
Therefore, the effects of HDACi 4b on denuded oocytes were
examined in HX-M199 and M199 media. In HX-M199 medium,
most of the oocytes in the control and HDACi 4b-treated groups
were arrested in the GV stage (Fig. 2i; Supplementary Fig. 5). In
M199 medium, most of the oocytes in the control and HDACi
4b-treated groups resumed meiosis (Fig. 2i; Supplementary Fig. 5).
These results demonstrated that HDACi 4b has no direct effect
on oocyte meiotic maturation.
Furthermore, to detect whether HDACi 4b affects develop-
mental competence, we performed transcriptome analysis of all
the mature oocytes in the control and HDACi 4b-treated groups.
The correlation coefficient between global transcripts in the
control and HDACi 4b-treated groups was >0.99, and no
differentially expressed genes were found (Fig. 2j and Supple-
mentary Data 1), indicating that HDACi 4b has no effect on
oocyte developmental competence.
Although HDAC3 and HDACi 4b controlled oocyte matura-
tion by regulating AREG expression was proved in this study,
other oocyte maturation-related factors regulated by HDAC3
remained unidentified. Therefore, we performed RNA-seq
analysis of ovarian GCs from Hdac3cKO and Hdac3flox/flox mice
and of GCs treated with HDACi 4b or control. Compared with
ovarian GCs from Hdac3flox/flox mice, those from Hdac3cKO mice
showed the differential expression of as many as 233 transcripts,
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with 78 upregulated transcripts, including Areg, and 155 down-
regulated transcripts (Fig. 2k and Supplementary Data 2). The
genes with the most pronounced changes in expression are shown
in Supplementary Fig. 6a. Impressively, more general transcrip-
tome changes were detected in GCs treated with HDACi 4b
in vitro than in those treated with the control: 2105 transcripts
were upregulated and 1301 transcripts were downregulated
(Supplementary Fig. 6c and Supplementary Data 3). The Gene
Ontology (GO) terms associated with the altered transcripts were
also analyzed (Supplementary Fig. 6b, d).
H3K14ac mediated HDAC3 and LH action regarding Areg
expression. It is well known that HDAC3 packages chromatin
into repressed domains via its HDAC activity22,23. To identify
which histone lysine residues are regulated by HDAC3 in GCs,
most of the histone acetylation modifications in GCs during LH/
hCG induction were assessed (Supplementary Fig. 7a, b). The
results showed that histone 3 lysine 14 acetylation (H3K14ac) was
markedly increased by LH/hCG induction in vivo and in vitro
(Fig. 3a, b; Supplementary Fig. 7c, d). ChIP analysis demonstrated
that H3K14ac levels at the Areg promoter were substantially
increased in GCs induced by LH/hCG (Fig. 3c), suggesting that
H3K14ac probably mediates the actions of LH/hCG on target
gene expression.
Furthermore, to elucidate whether HDAC3 inhibits AREG
expression by repressing H3K14ac, GCs from HDAC3 knockout
mouse ovaries or HDACi 4b-treated follicles were examined.
H3K14ac levels were significantly increased in ovarian GCs from
Hdac3cKO mice compared with Hdac3flox/flox mice (Fig. 3d).
Furthermore, ChIP analysis revealed that H3K14ac levels at the
Areg promoter were obviously increased in GCs from Hdac3cKO
mouse ovaries compared with Hdac3flox/flox mouse ovaries
(Fig. 3e). Correspondingly, H3K14ac levels were much higher
in HDACi 4b-treated GCs than in control GCs (Fig. 3f). ChIP
analysis showed that HDACi 4b increased H3K14ac levels at the
Areg promoter in GCs in vitro (Fig. 3g). Therefore, H3K14ac is
key for the regulation of AREG expression by both LH and
HDAC3. The results unanimously confirmed our hypothesis that
HDAC3 decreases H3K14ac levels in vivo and in vitro before LH
induction.
FOXO1 potentially recruited HDAC3 to the Areg promoter.
Among the class I HDAC family, HDAC3 is the only member
that functions through interacting with NCoR1/2 and TBL1X/
TBL1XR, forming the core of the NCoR transcriptional repressor
complex through its deacetylase activation domain24. In line with
this finding, we performed coimmunoprecipitation (Co-IP) of
HDAC3 coupled with mass spectrometry (MS) to identify factors
that bind HDAC3 to repress Areg expression. The core members
of the NCoR complex, NCoR1, NCoR2, and TBL1X, were all
identified in the HDAC3 antibody group compared with the
immunoglobulin G (IgG) group (Fig. 4a; Supplementary Data 4
and 5).
Another important unknown is the transcription factor that
recruits the HDAC3-NCoR complex to the Areg promoter. We
performed DNA pulldown coupled with MS analysis and
searched for predicted transcription factor-binding sites using
the JASPAR database. By comparing the proteins captured by
Areg promoter DNA with the transcription factor-binding data
predicted by JASPAR, four candidate transcription factors,
namely, SP1, FOXO1, GATA4, and Myod1, were identified
(Fig. 4b; Supplementary Data 6 and 7). However, none of these
transcription factors were identified by HDAC3 Co-IP (Fig. 4a;
Supplementary Data 4 and 5), indicating that they potentially
interact with the HDAC3-NCoR complex rather than with
HDAC3 directly. Therefore, we performed cross-linking Co-IP
followed by MS to examine all of the proteins directly or
indirectly interacting with HDAC3 on chromatin25. Western
blotting analysis of cross-linking Co-IP against HDAC3 showed
that numerous HDAC3 complexes were successfully captured in
the HDAC3 IP group compared to the negative IgG group
(Fig. 4c). As expected, MS data analysis identified many
transcription factors among the HDAC3 interactors on chroma-
tin, including the enrichment of NCoR complex components
(Supplementary Data 8). However, only FOXO1, GATA4, and
Myod1, but not SP1, were found among the HDAC3 interactors,
indicating that these three transcription factors potentially
interact with the HDAC3 complex at the Areg promoter (Fig. 4b;
Supplementary data 8). Furthermore, the interaction between
FOXO1 and HDAC3 was confirmed by reverse cross-linking Co-
IP coupled with western blotting (Fig. 4d). Therefore, we
concluded that one or more of the FOXO1, GATA4, and Myod1
transcription factors are potentially recruited by HDAC3 to the
Areg promoter before the LH surge.
HDAC3 and LH affected Areg expression by regulating SP1
recruitment to the Areg promoter. Histone acetylation induces
gene expression by causing chromatin unfolding and increasing
transcription factor access15; thus we aimed to identify the
transcription factors that bind to the Areg promoter and initiate
Fig. 2 HDAC3 repressed AREG expression in GCs before the LH surge. a Quantitative real-time PCR revealed Areg expression in Hdac3flox/flox and
Hdac3cKO GCs after PMSG treatment. Data are presented as mean ± SEM. Asterisks (*) indicate significant differences at ***P= 0.000003 determined by
the two-sided t test. b AREG levels in Hdac3flox/flox and Hdac3cKO GCs were quantified by western blotting analysis. n= 3 biologically independent
experiments. Data are presented as mean ± SEM. Asterisks (*) indicate significant differences at ***P= 0.0009 determined by the two-sided t test.
c Quantitative real-time PCR showed that inhibiting HDAC3 increased Areg expression in GCs in vitro. HDACi 4b, an HDAC3 inhibitor. Data are presented as
mean ± SEM. Asterisks (*) indicate significant differences at ***P= 5.15E−5 determined by the two-sided t test. d AREG levels in control and HDACi
4b-treated GCs were quantified by western blotting analysis. n= 3 biologically independent experiments. Data are presented as mean ± SEM. Asterisks (*)
indicate significant differences at ***P= 3.27E−5 determined by the two-sided t test. e Representative images demonstrate the effect of GC-derived HDAC3
on cumulus cell expansion within in vitro cultured COCs. Scale bar= 100 µm. n= 3 biologically independent experiments. f Oocyte maturation (GVBD) rates
were significantly improved by HDACi 4b, and this effect was reversed by AG1478. AG1478, EGFR inhibitor. n= 3 biologically independent experiments.
Data are presented as mean ± SEM, and different letters (a–c) indicate significant differences among groups (two-sided ANOVA and Holm–Šidák test),
P (a, b) < 0.001, P (a, c) < 0.05, P (b, c) < 0.001. g ChIP-qPCR analysis of HDAC3 at the Areg promoter (−343 to −150) before and after the LH surge. n= 3
biologically independent experiments. Data are presented as mean ± SEM, and different letters (a–b) indicate significant differences among groups (two-
sided ANOVA and Holm–Šidák test), P (a, b) < 0.001. h HDACi 4b was unable to rescue 8-Br-cGMP-mediated inhibition of oocyte maturation (GVBD). Data
are presented as mean ± SEM, and different letters (a–b) indicate significant differences among groups (two-sided ANOVA and Holm–Šidák test), P (a, b) <
0.001. i HDACi 4b had no direct effect on denuded oocyte meiotic maturation. j Scatter plot comparison of oocyte transcripts between the control and
HDAC3 inhibitor groups revealed that HDACi 4b had no effect on oocyte developmental competence. Pearson statistical test used for statistical analysis.
k Volcano plot of transcriptomic analysis of GCs isolated from Hdac3flox/flox and Hdac3cKO ovaries. Source data are provided as a Source Data file.
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Fig. 3 H3K14ac mediated the effects of HDAC3 and LH on Areg expression. a H3K14ac levels were increased by hCG in a time-dependent manner. n= 3
biologically independent experiments. Data are presented as mean ± SEM, and different letters (a–d) indicate significant differences among groups (two-
sided ANOVA and Holm–Šidák test), P (a, b) < 0.01, P (a, c) < 0.01, P (a, d) < 0.001, P (b, c) < 0.05, P (b, d) < 0.01, P (c, d) < 0.05. b Immunostaining
revealed that LH increased H3K14ac (green) levels in GCs in vivo. Nuclei were dyed with Hoechst (blue). Scale bar= 100 µm. n= 3 biologically
independent experiments. c ChIP-qPCR analysis of H3K14ac at the Areg promoter (−343 to −150) before and after the LH surge. P48: 48 h after PMSG
treatment. H1–H4: 1–4 h after hCG treatment. Data are presented as mean ± SEM, and different letters (a–c) indicate significant differences among groups
(two-sided ANOVA and Holm–Šidák test), P (a, b) < 0.01, P (a, c) < 0.001, P (b, c) < 0.001. d H3K14ac levels in Hdac3flox/flox and Hdac3cKO GCs were
quantified by western blotting analysis. n= 3 biologically independent experiments. Data are presented as mean ± SEM. Asterisks (*) indicate significant
differences at ***P < 0.001 determined by the two-sided t test. e ChIP-qPCR analysis of H3K14ac at the Areg promoter in Hdac3flox/flox and Hdac3cKO GCs.
Data are presented as mean ± SEM, and different letters (a–c) indicate significant differences among groups (two-sided ANOVA and Holm–Šidák test),
P (a, b) < 0.001, P (a, c) < 0.001, P (b, c) < 0.05. f Western blotting analysis showed that HDACi 4b (HDAC3 inhibitor) substantially increased H3K14ac
levels. n= 3 biologically independent experiments. Data are presented as mean ± SEM. Asterisks (*) indicate significant differences at ***P < 0.001
determined by the two-sided t test. g ChIP-qPCR analysis of H3K14ac at the Areg promoter in control and HDACi 4b-treated GCs. Data are presented as
mean ± SEM, and different letters (a–c) indicate significant differences among groups (two-sided ANOVA and Holm–Šidák test), P (a, b) < 0.001, P (a, c) <
0.001, P (b, c) < 0.001. Source data are provided as a Source Data file.
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transcription upon removal of HDAC3. We found that AREG
expression induced by HDAC3 inhibition was reversed by
mithramycin A (MIT), a specific inhibitor of the transcription
factor SP1 (Fig. 5a), suggesting that SP1 is involved in Areg
transcription after HDAC3 downregulation. Although HDACi 4b
and Hdac3 knockout had no effect on SP1 expression in vitro
(Fig. 5b) or in vivo (Fig. 5d), respectively, ChIP analysis revealed
increased SP1 protein recruitment to the HDAC3-binding site on
the Areg promoter in HDACi 4b-treated GCs compared with
control cells (Fig. 5c). Correspondingly, Hdac3 deletion in ovarian
GCs significantly increased SP1 occupancy at the Areg promoter
(Fig. 5e). Collectively, the loss of HDAC3 and the acetylation of
H3K14 promoted SP1 binding to the Areg promoter.
To investigate the role of SP1 under more physiological
conditions, we examined the effect of SP1 on LH-induced AREG
expression. MIT notably reversed the high AREG levels induced
by LH (Fig. 5f), suggesting that SP1 is involved in Areg
transcription induced by LH. Consistently, SP1 protein levels in
GCs were unaffected by LH during oocyte maturation (Fig. 5g),
whereas ChIP analysis revealed that LH strongly promoted SP1
recruitment to the HDAC3-binding site on the Areg promoter
(Fig. 5h). Taken together, these data indicated that LH induces
H3K14ac and increases SP1 access to the Areg promoter.
The HDAC3 inhibitor improved mouse oocyte maturation and
developmental competence. In light of our findings demon-
strating that the inhibition of GC-derived HDAC3 induces oocyte
maturation independent of LH action, we assessed whether
HDAC3 is a potential target to improve the developmental
capacity of oocytes undergoing in vitro maturation (IVM) inde-
pendent of LH. Briefly, HDACi 4b was applied to cultured mouse
COCs with mGC feeders, which is known as the HDACi 4b-GC
feeder system. Although the oocyte GVBD rate of COCs was
similar between the control and HDACi 4b groups (93% vs. 94%,
respectively; P > 0.05) (Fig. 6a), the ratio of metaphase II (MII)
oocytes was 1.9-fold higher in the HDACi 4b group than in the
control group (85% vs. 45%, P < 0.01) (Fig. 6b), demonstrating
that our system promoted the GV to MII transition in oocytes.
Then oocyte developmental capacity was further evaluated. In
brief, all the MII-stage oocytes obtained from the IVM system
were used for IVF. After 4 days of in vitro culture (IVC) of
fertilized eggs, up to 2.2-fold more blastocysts were obtained from
the HDACi 4b group than from the control group (Fig. 6c, d). The
embryo transfer assay demonstrated that the blastocysts in
the HDACi 4b group could undergo full pregnancy and even
produce slightly more pups, although the difference in pup
number was not statistically significant (Fig. 6e, f). Interestingly,
the body weights of the pups in the control and HDACi 4b groups
at 3 days after birth were similar (Fig. 6g). Collectively, by
targeting HDAC3, our IVM system promotes oocyte nuclear and
cytoplasmic development competence independent of LH.
Discussion
Physiologically, the final stage of oocyte maturation requires close
cooperation between oocytes and GCs within the follicles25.
Consistent with this finding, LH response failure leads to failed
oocyte maturation and ovulation, and this response is related to
abnormal gene expression in GCs1,9,26–29. It is therefore rea-
sonable to hypothesize that an essential inhibitory mechanism in
GCs may exist that restrains gene expression important for
resuming oocyte maturation before the LH induction. The
inability to repress the expression of these genes leads to the
gonadotropin-independent resumption of meiosis, which inter-
rupts the synchrony between oocyte maturation and ovulation
and compromises female fertility3. Surprisingly, this study
revealed an epigenetic modification mechanism in GCs that
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histone acetylation by HDAC3 is essential for gonadotropin-
induced oocyte maturation (Supplementary Fig. 8).
EGF-like growth factors mediate the effect of LH on oocyte
maturation30. Among these factors, AREG is the most abundant
and important protein26. The Areg knockout mouse has severely
impaired fertility31, and AREG levels in follicular fluid are posi-
tively correlated with the number of available embryos in
humans32. However, given the significant differences in bioac-
tivity between endogenous and recombinant AREG, the
concentration of recombinant AREG necessary to promote
cumulus expansion and oocyte maturation in vitro is approxi-
mately 20-fold higher than that detected in follicular fluid26.
Therefore, employing GC-secreted AREG to improve oocyte
maturation in vitro may be a more efficient and physiological
strategy. Here AREG expression in both GCs and cumulus cells is
essential for oocyte maturation under physiological conditions19.
HDAC3 regulates AREG expression in both GCs and cumulus
cells (Fig. 2a–d; Supplementary Fig. 4a, b). Combined with the
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result that the LH surge decreased HDAC3 levels in GCs and
cumulus cells (Fig. 1a, b; Supplementary Fig. 1b, c), LH decreases
HDAC3 protein levels in mGCs directly and in cumulus cells
indirectly, resulting in increased AREG expression levels in both
mGCs and cumulus cells and oocyte maturation. However, AREG
may not be the sole target of HDACi 4b; supplementing the IVM
medium with AG1478, a specific inhibitor of the AREG receptor
(EGFR), did not prevent 10–20% of oocytes from maturing.
Therefore, other unknown oocyte meiosis-related factors may be
regulated by HDAC3 in GCs.
The reasons why altered expression of more genes was
observed following treatment with the HDACi 4b inhibitor
compared with genetic loss of HDAC3 could be versatile.
According to our study, the expression of Hdac3 in the ovarian
GCs was only partially depleted whenever Hdac3 was deleted in
Hdac3cKO females by administration of tamoxifen because of the
low efficiency of induced gene knockout. As one of the inhibitors
of HDAC3, HDACi 4b is also functional in inhibiting the activity
of HDAC1. However, HDACi 4b showed a ~3-, ~25-, and
~72-fold selectivity for HDAC3 over HDAC1, 2, and 8 respec-
tively, and essentially no activity against other HDAC subfamily
members18. The concentration of HDACi 4b we used in this
paper was the lowest effective concentration based on our pre-
assays, which means that HDACi 4b at this specific concentration
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could mimic the effect of HDAC3 depletion on AREG expression
and oocyte maturation in vivo. In this study, more altered
expression of genes was observed following HDACi 4b treatment,
instead of the in vivo group (Supplementary Fig. S6). Taking into
account these above reasons, it is therefore understandable the
differences between the data obtained in vivo resulting from
HDAC3 partially depleted GCs and the data obtained in vitro
resulting from HDAC3 fully inhibited GCs. Anyway, the
expression of Areg in ovarian GCs was significantly increased in
both Hdac3cKO mice and HDACi 4b-treated GCs, which is
in agreement with other results obtained in vitro and in vivo.
In sum, Areg is an essential target gene of HDAC3 in mediating
gonadotropin action on oocyte maturation.
Although HDACi 4b preferentially targets HDAC3 and had
limited in vitro and in vivo toxicity18, an evaluation of the safety
of HDACi 4b is still necessary before blastocysts produced with
this system could be considered for practical use. Despite that
HDAC1/3 belongs to the same class and directly interact in some
cases, their cell type- and developmental stage-specific physiolo-
gical actions may be distinct33. Interestingly, among all class I
family HDACs currently identified in humans34, only HDAC3
responded to LH in preovulatory follicles in this study.
Physiologically, ovarian GCs mediates the action of gonado-
tropins on oocyte maturation and ovulation in the periovulatory
follicles. Our results proved that, although the transcription fac-
tors (such as SP1) of AREG exists before LH surge in mGCs, these
transcription factors cannot initiate AREG expression because the
accessibility of Areg promoter is blocked by HDAC3. The findings
emphasized the pivotal role of epigenetic modification of histone
acetylation for the specifically open and closed of FSH and LH
target genes in mGCs during oocyte maturation.
Methods
Animal strains. C57BL/6J female mice were raised in colonies maintained by the
investigators. Mice aged 21–23 days received an i.p. injection of 5 IU of PMSG
(Sansheng Pharmaceutical Co., Ltd., Ningbo, China) to stimulate follicle growth.
Forty-six to 48 h later, the mice received an i.p. injection of 5 IU of hCG (Sansheng
Pharmaceutical Co., Ltd., Ningbo, China) to induce oocyte maturation and ovu-
lation. Hdac3flox/flox mice were purchased from the Jackson Laboratory (ME, USA),
and Foxl2-CreERT2 mice were a gift from Dr. Liu Kui. All of these mice were
housed under controlled temperature (22 °C) and light conditions (14 h light, 10 h
darkness; lights on at 07:00 a.m.) and allowed free access to chow and water.
Briefly, to obtain the Hdac3cKO mice, we crossed the Hdac3flox/flox females with
Hdac3flox/flox plus Foxl2-CreERT2 males without tamoxifen treatment. Therefore,
the offsprings with Hdac3flox/flox but without Foxl2-CreERT2 were used as controls.
The experiments were performed in accordance with the principles and guidelines
for the use of laboratory animals of China Agricultural University and approved by
the Institutional Animal Care and Use Committee of China Agricultural
University.
Tamoxifen administration in Foxl2-CreERT2; Hdac3fl/fl mice. Tamoxifen was
resuspended to a concentration of 100 mg/mL in 95% ethanol and further diluted
with corn oil to a final concentration of 20 mg/mL. A single i.p. injection of
tamoxifen (20 mg/kg body weight) was administered, respectively, to 18-day-old
Hdac3flox/flox; Foxl2-CreERT2 female mice and Hdac3flox/flox female mice (controls).
Chemicals, hormones, and media. All chemicals were purchased from Sigma-
Aldrich (St. Louis, MO, USA) unless otherwise noted. Media used for all experi-
ments were obtained from Gibco (Life Technologies, CA, USA). All of the anti-
bodies against histone acetylation were purchased from Active Motif (Shanghai,
China) with the exception of the H3K14ac antibody, which was purchased from
EpiGentek (Farmingdale, NY, USA). Other antibodies used in this paper are
presented in Supplementary Table 3.
Follicle, COC, and mGC culture. Follicles were isolated from the ovaries of PMSG-
primed mice and cultured in M199 medium with ITS (insulin–transferrin–sodium
selenite media supplement). To investigate the effect of the HDAC3 inhibitor
HDACi 4b (sc207902, Santa Cruz Biotechnology, CA, USA) on oocyte maturation
in vitro, the follicles were cultured for 16 h with or without 5 μM HDACi 4b.
Furthermore, to investigate the role of SP1 in AREG expression, 1 μM MIT, an SP1
inhibitor, was added to both HDACi 4b-treated follicles and LH-treated follicles for
4 h. Gene expression in all these groups was examined at the end of the culture
period.
Previous studies reported that PMSG was able to mimic the action of FSH in
follicle development, and hCG mimicked the effects of LH on oocyte maturation
and ovulation35–37. Therefore, PMSG and hCG are widely used as substitutes for
FSH and LH in others’ and our studies. Here COCs and mGCs were collected with
a micropipette by puncturing large antral follicles with oocytes at the GV stage
from the ovaries of mice that were pretreated with PMSG for 46–48 h. The
collected mGCs and COCs were maintained in hypoxanthine (HX)-IVM medium
(M199 medium containing 4 mM HX, 75 g/mL penicillin G, 50 g/mL streptomycin
sulfate, 0.29 mM pyruvate, and 3 mg/mL bovine serum albumin (BSA)). To
promote cell attachment, mGCs were cultured in IVM medium with 10% fetal
bovine serum (FBS). Before COC culture, mGCs were treated with or without 5 μM
HDACi 4b overnight to investigate the effect of mGC-derived HDAC3 on oocyte
maturation. Then COCs were added to the mGC feeders and cocultured for 16 h
with 30 nM NPPC. Furthermore, to elucidate whether AREG mediates the effects
of HDAC3 on oocyte maturation, 1 μM AG1478, an EGFR inhibitor, was added to
the mGC feeder medium. The GVBD ratio of oocytes in these COCs was analyzed.
In addition, samples of mGCs and COCs were centrifuged, frozen, and stored at
−80 °C for subsequent mRNA or protein expression analysis.
Follicles, oocytes, COCs, and mGCs were cultured at 37 °C in a controlled
atmosphere of 5% CO2 and 95% air throughout the study.
RNA preparation and analysis. RNA was isolated from cultured cells and follicles
using TRIzol Reagent (Invitrogen, Life Technologies, CA, USA) according to the
manufacturer’s protocol. The quantity and quality of total RNA were assessed
using a Nanodrop spectrophotometer (Thermo Scientific, USA). Reverse tran-
scription (RT) (Promega Reverse Transcription System) was performed using 1 μg
of total RNA per sample. qPCR was conducted and analyzed on an ABI 7500
Sequence Detection System (Applied Biosystems, USA) using a standard protocol.
The primers used for test genes are listed in Supplementary Table 1. For RNA-seq
analysis of ovarian GCs from Hdac3flox/flox and Hdac3cKO mice, total RNA
extracted from Hdac3flox/flox and Hdac3cKO mouse ovaries was analyzed by
Annoroad Gene Technology Co., Ltd. (Beijing, PR China). Furthermore, for single-
cell RNA-seq analysis of oocytes cultured with or without HDACi 4b, RNA was
extracted from 35 oocytes per group, and transcriptome analysis was performed by
Annoroad Gene Technology Co., Ltd. (Beijing, PR China).
Chromatin immunoprecipitation. To clarify whether HDAC3 directly binds to the
Areg promoter, ChIP analysis was performed as described in the ChIP Assay Kit
instructions (17–371, Millipore, MA, USA). In brief, cells extracted from mouse
ovaries in vivo or cultured cells in vitro were cross-linked with 1% formaldehyde
for 10 min at room temperature and neutralized by glycine at a final concentration
of 0.125 M. After three washes with ice-cold phosphate-buffered saline (PBS), cell
pellets were lysed in 1% sodium dodecyl sulfate (SDS) buffer containing a protease
inhibitor. Then chromatin was sheared by sonication until the average DNA length
was approximately 300–500 bp, as evaluated by 1% agarose gel electrophoresis.
Sheared chromatin was diluted in ChIP dilution buffer to a final SDS concentration
of 0.1%. Then salmon sperm DNA/protein agarose slurry was added to preclear the
chromatin solution. One percent of the chromatin fragment sample was stored at
4 °C for later use as nonprecipitated total chromatin (input) for normalization. The
remaining chromatin fragments (99%) were incubated overnight at 4 °C with 3 μg
of anti-HDAC3 antibody. Normal rabbit IgG (17–601, Millipore, MA, USA) was
used as a negative control for nonspecific immunoprecipitation. The
chromatin–antibody complex was incubated with protein A/G beads for 1 h at
4 °C. The antibody/DNA complexes on agarose beads were collected by cen-
trifugation. The beads were washed with various buffers in the following order:
low-salt immune complex buffer, high-salt immune complex buffer, LiCl immune
complex buffer, and TE buffer provided by the supplier. Then the beads were
suspended in elution buffer, and precipitated protein/DNA complexes were eluted
from the antibodies/beads. The resulting protein/DNA complexes were then sub-
jected to cross-link reversal in 0.2 M NaCl at 65 °C for 10 h, followed by the
addition of 10 mM EDTA, 40 mM Tris-HCl, and 40 μg/ml proteinase K and
incubation at 55 °C for 2 h. DNA was purified by phenol/chloroform extraction
and ethanol precipitation. Specific primers (Supplementary Table 2) were used to
detect immunoprecipitated chromatin fragments and input chromatin.
Immunofluorescence. Ovaries and follicles were fixed in cold 4% paraformalde-
hyde (PFA) for 48 and 24 h, respectively. Then the samples were dehydrated in
ethanol and toluene, embedded in paraffin, and sectioned at 5-μm thickness.
Ovaries and follicles were transferred to 3-aminopropyl-triethoxysilane-treated
microscope slides (ZLI-9001, Zhongshan Company, Beijing, China) for immuno-
fluorescence staining. In brief, sections were deparaffinized and rehydrated, and
antigen retrieval was performed by microwaving for 15 min in 0.01% sodium
citrate buffer (pH 6.0). For immunofluorescence analysis, sections were blocked
with 10% normal donkey serum and incubated overnight at 4 °C with primary
antibodies against HDAC3 before incubation with Alexa Fluor 488- or 555-
conjugated secondary antibodies (1:100, Invitrogen, Life Technologies, CA, USA)
for 1 h at 37 °C and propidium iodide (421301, BioLegend, CA, USA) or Hoechst
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33342 (B2261; Sigma-Aldrich, USA) as a nuclear counterstain. Samples were
observed under a microscope.
Immunohistochemistry (IHC). For IHC, ovary sections were treated with 3%
H2O2 in PBS for 20 min to quench endogenous peroxidase activity. Nonspecific
binding was blocked with 5% BSA in PBS. Sections were then incubated overnight
at 4 °C with the primary antibodies, incubated for 20 min at room temperature
with horseradish peroxidase-labeled goat anti-rabbit IgG (Zhongshan Company,
Beijing, China), and rinsed with PBS. The antibody complex was detected using
DAB reagent according to the manufacturer’s instructions (Zhongshan Company,
Beijing, China).
Periodic acid Schiff (PAS) staining. To detect the corpora amylacea marker PAS,
the sections were incubated in 0.5% periodic acid (Solarbio Company, Beijing,
China) for 5 min at room temperature, followed by washing in tap water for 1 min.
Then the sections were incubated in Schiff reagent (Solarbio Company, Beijing,
China) for 10 min, followed by washing in tap water for 10 min. After the sections
were rinsed in PBS for 10 min, the nuclei were stained with hematoxylin.
Coimmunoprecipitation. Fresh GCs were collected from the ovaries of 22–24-day-
old female mice following stimulation with 5 IU of PMSG for 46 h. Lysis buffer was
added, and samples were centrifuged to obtain total protein. HDAC3 immuno-
precipitation was performed according to the protocols of Dynabeads Protein G
Immunoprecipitation Kit (Invitrogen, USA), as summarized below. Dynabeads
were resuspended in Binding & Washing buffer containing 5 μg of anti-HDAC3
antibody and incubated for 40 min with rotation at room temperature.
Dynabead–antibody complexes were then washed with Binding and Washing
buffer. Then protein lysates were added for 1 h at room temperature with rotation,
and the Dynabead–antibody–antigen complexes were washed thrice. Next, the
complex was gently resuspended in 20 μL of elution buffer and incubated for 5 min
at 70 °C. The supernatant was transferred to a new tube and boiled in elution buffer
for 10 min in a water bath at 100 °C. The nonspecific binding control was incu-
bated with normal rabbit IgG (sc-2763, Santa Cruz Biotechnology, CA, USA). The
supernatants of both the control and HDAC3 groups were subjected to liquid
chromatography coupled with MS in the MS laboratory of China Agriculture
University to identify all proteins that interacted with HDAC3.
Immunoblotting. Total protein was extracted in WIP (CellChip, BJ Biotechnology
Co., Ltd., Beijing, China) as recommended by the manufacturer. In brief, total
protein from each sample was separated by 10% SDS-polyacrylamide gel electro-
phoresis and then electrophoretically transferred onto polyvinylidene fluoride
membranes (IPVH00010, Millipore, MA, USA). The membranes were then
incubated for 1 h at room temperature with 5% BSA, followed by an overnight
incubation at 4 °C with an anti-HDAC3 antibody. After being washed in TBST,
the membranes were incubated with secondary antibody (1:5000, ZB-2301 and
ZB-2305, ZSGB-BIO, Beijing, China) in TBST, followed by detection with the
SuperSignal chemiluminescent detection system (34080, Thermo Scientific, CA,
USA). Glyceraldehyde 3-phosphate dehydrogenase was used as an internal control.
DNA pulldown assay and bioinformatic analysis with JASPAR. To identify
transcription factors that bind to the Areg promoter, DNA pulldown assays were
performed as described previously38. Briefly, fresh GCs were collected from the
ovaries of 22–24-day-old female mice stimulated with 5 IU of PMSG for 46 h and
the nuclei were extracted from GCs with Buffer A (10 mM HEPES, pH 7.9, 1.5 mM
MgCl2, 10 mM KCl, 300 mM sucrose, and 0.5% NP-40). Nuclear protein was
extracted from GC nucleus with NE (20 mM HEPES (pH7.9), 1.5 mM MgCl2,
0.5 M NaCl, 0.2 mM EDTA and 20% glycerol) and NET (Make up to 1% Triton-X-
100, 1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride in NE buf-
fer) buffer as described38. Then primers targeting the Areg promoter (−343 to
−150) were synthesized with a 5′ biotin label, resulting in 5′-biotinylated double-
strand DNA probes. The DNA probes were incubated overnight with the extracted
nuclear proteins. The DNA–protein complexes were incubated with streptavidin-
agarose beads (20347, Thermo Scientific, CA, USA) for 1 h. The
DNA–protein–streptavidin bead complexes were washed three times with PBS.
Finally, the complexes were eluted and subjected to MS analysis in the MS
laboratory of China Agriculture University. For the bioinformatic analysis of
potential transcription factor binding to the Areg promoter with JASPAR, we
uploaded the Areg promoter sequence (from −343 to −150) onto the http://jaspar.
genereg.net/ website.
Cross-linking Co-IP and reverse cross-linking Co-IP. To identify all the inter-
actors of HDAC3 at chromatin, we performed cross-linking Co-IP assays as
described previously24. Briefly, fresh GCs were collected from the ovaries of
22–24-day-old female mice stimulated with 5 IU of PMSG for 46 h. Nuclear pro-
teins were extracted from GCs with Buffer A (10 mM HEPES, pH 7.9, 1.5 mM
MgCl2, 10 mM KCl, 300 mM sucrose, and 0.5% NP-40) as described39. Then the
nuclei were fixed with 1% formaldehyde diluted in PBS for 10 min at 37 °C. Cross-
linked samples were quenched with glycine, washed once with PBS, and
resuspended in 1 ml NCB (20 mM Tris-HCl pH 8, 100 mM KCl, 5 mM MgCl2, 10%
glycerol, 0.1% NP-40, and 1 mM DTT) supplemented with EDTA-free protein
inhibitor cocktail (Millipore). Lysates were sonicated with a probe sonicator
(Ningbo, China). Then the cross-linked chromatin extracts were cleared by cen-
trifugation and subsequently treated with 1000 Kunitz units of Benzonase (Sigma)
for 30 min at 30 °C. The extracts were immunoprecipitated overnight with anti-
HDAC3 magnetic beads (16–663, Millipore, MA, USA) or normal IgG magnetic
beads. Then the complexes were washed three times and eluted with elution buffer
for MS analysis in the MS laboratory of China Agriculture University. To confirm
the interaction between FOXO1 and HDAC3, the cross-linking of the proteins
eluted from the complexes was reversed by heating at 65 °C overnight with 0.2 M
NaCl. Then the reverse cross-linked proteins were analyzed by western blotting.
Oocyte IVM, IVF, and early embryo IVC. Four- to 5-week-old mice were used for
this experiment. The mGCs retrieved from mice were cultured in Nunc IVF 4-well
dishes (Thermo Scientific, Life Technologies, CA, USA) with IVM medium con-
taining 10% FBS with or without 5 μM HDAC3 inhibitor. The medium was cov-
ered with mineral oil (M8410, Sigma). The collected COCs were cocultured with
mGC feeders. COCs in both groups were digested with hyaluronidase (90017,
Vitrolife, Sweden) before examining meiosis progression. Oocytes at the MII stage
in both groups were used for IVF. Mouse sperm capacitation was induced with IVF
medium (Vitrolife, Sweden) for 1 h. Then sperm were mixed with MII oocytes in
IVF medium for 6 h. Fertilization was confirmed by monitoring pronuclear for-
mation. Then zygotes were transferred to G1 plus medium (Vitrolife, Sweden) and
cultured until the embryos reached the eight-cell stage. Then zygotes were trans-
ferred into G2 plus medium (Vitrolife, Sweden) for further culture. The number of
blastocysts was calculated and analyzed. The embryos were transferred into the
uterus of a 2.5-day postcoital pseudopregnant female mice as previously
described38.
TUNEL. For TUNEL assays, ovaries were collected from Hdac3flox/flox and
Hdac3cKO mice and fixed in cold 4% PFA for 1 h. The tissues were embedded in
paraffin wax and serially sectioned at 5 μm. Apoptotic cells were detected using a
TUNEL Apoptosis Detection Kit (Invitrogen, Life Technologies, USA) after
HDAC3 immunostaining.
Statistical analysis. All analysis were performed using Graph Pad Prism version 7
for Windows (GraphPad Software, La Jolla, CA, USA). Data for RT-PCR assays,
follicle and oocyte counting experiments, and breeding tests are presented as mean
± SEM, and each experiment was performed in triplicate. Data were analyzed using
t test or analysis of variance. Values of P < 0.05 were considered statistically
significant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
RNA-seq data have been submitted to the NCBI Gene Expression Omnibus (GEO;
http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE139666 for the
SuperSeries record of the three groups of RNA-seq data, including GSE139663,
GSE139664, and GSE139665, respectively, for the transcriptome of HDAC3cKO mice
ovarian mGCs, the cultured ovarian mGCs treated with HDACi 4b, and the cultured
oocytes treated with HDACi 4b. Proteomics data of Fig. 4 are available in Supplementary
Data 4–8. The reporting summary and editorial checklist for this article are available as a
Supplementary file.
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